<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01236651</url>
  </required_header>
  <id_info>
    <org_study_id>dr hegab protocol</org_study_id>
    <nct_id>NCT01236651</nct_id>
  </id_info>
  <brief_title>Meperidine Versus Drotaverine Regarding the Effect on the Duration of the First Stage of Labor in Full Term Primigravidae</brief_title>
  <official_title>Comparison Between Meperidine and Drotaverine Regarding the Effect on the Duration of the First Stage of Labor in Full Term Primigravidae</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparison Between Meperidine and Drotaverine Regarding the Effect on the Duration of the
      First Stage of Labor in Full Term Primigravidae
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Comparison Between Meperidine and Drotaverine Regarding the Effect on the Duration of the
      First Stage of Labor in Full Term Primigravidae

      Protocol of Thesis Submitted for partial fulfillment of master degree in Obstetrics &amp;
      Gynecology

      The aim of this work is to compare and to evaluate the efficacy of drotaverine hydrochloride
      versus meperidine hydrochloride on the duration of the 1st stage of labor.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>November 2010</start_date>
  <completion_date type="Anticipated">September 2011</completion_date>
  <primary_completion_date type="Anticipated">April 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the duration of the first stage of labor</measure>
    <time_frame>6 monthes</time_frame>
    <description>the primary outcome is to evaluate whether meperidine or drotaverine is more effective in shortening the duration of the 1st stage of labor</description>
  </primary_outcome>
  <primary_outcome>
    <measure>effect on the duration of the 1st stage of labor</measure>
    <time_frame>6 monthes</time_frame>
    <description>the primary outcome is to evaluate whether meperidine or drotaverine is more effective on the duration of the 1st stage of labor</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>effect on pain</measure>
    <time_frame>6 monthes</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Effect of Meperidine or Drotaverine on Effacement and Dilatation of the Cervix During Labor in Full Term Primigravidae</condition>
  <arm_group>
    <arm_group_label>meperidine and duration of 1st stage of labor</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>meperidine 100mg i.v in 1st stage of labor and calculate the duration of the 1st stage of labor</description>
  </arm_group>
  <arm_group>
    <arm_group_label>drotaverine and duration of 1st stage of labor</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>drotaverine 40mg i.v in 1st stage of labor and calculate the duration of the 1st stage of labor</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Meperidine</intervention_name>
    <description>administer 100mg meperidine i.v during the 1st stage of labor and calculate the duration of this stage of labor</description>
    <arm_group_label>meperidine and duration of 1st stage of labor</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Drotaverine</intervention_name>
    <description>administer 40mg drotaverine i.v during the 1st stage of labor and calculate the duration of this stage of labor</description>
    <arm_group_label>drotaverine and duration of 1st stage of labor</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: ● primigravida.

          -  Singleton pregnancy.

          -  Term gestation i.e, 38-41 weeks.

          -  Sure, reliable dates documented by ultrasound in the 1st half of pregnancy.

          -  Vertex presentation with occipito anterior position.

          -  Efficient uterine contractions at a rate of at least 3 to 4 contractions every 10
             minutes, each contraction lasting for at least 40 seconds.

        Exclusion Criteria: ● Abnormal presentation or occipito posterior position.

          -  Multiple pregnancies.

          -  Cephalo-pelvic disproportion.

          -  Cervical surgery in the past or history of cervical injury.

          -  Patients on antihypertensive therapy.

          -  Known hypersensitivity to drotaverine or meperidine.

          -  If any other spasmolytic agent had been used within 48 hours.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>mahmoud mohamed</last_name>
    <phone>0020106981179</phone>
    <email>hegab_2008@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>M H</last_name>
    <phone>0020114440015</phone>
    <email>hegab_2008@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mahmoud</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <phone>0020106981179</phone>
    </contact>
    <contact_backup>
      <phone>0020123033223</phone>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 8, 2010</study_first_submitted>
  <study_first_submitted_qc>November 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 9, 2010</study_first_posted>
  <last_update_submitted>November 8, 2010</last_update_submitted>
  <last_update_submitted_qc>November 8, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 9, 2010</last_update_posted>
  <responsible_party>
    <name_title>ain shams university</name_title>
    <organization>ain shams university</organization>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Meperidine</mesh_term>
    <mesh_term>Drotaverin</mesh_term>
    <mesh_term>Papaverine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

